PT Millennium Pharmacon International Tbk

IDX:SDPC.JK

143 (IDR) • At close October 30, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) IDR.

202320222021202020192018201720162015201420132012201120102009
Omzet 3,363,517.8083,200,833.0962,988,848.5662,643,626.5052,726,755.4132,376,182.7392,110,824.9731,970,114.2761,707,613.431,437,667.5631,310,244.1551,172,974.793973,210.721836,964.1471,010,934.004
Kosten van de omzet 3,090,142.4332,931,198.4522,747,094.9962,421,934.8982,497,998.5462,166,0271,931,226.8241,800,872.5281,550,312.6381,306,133.3521,189,781.9571,068,515.421885,991.104756,729.731916,547.64
Brutowinst 273,375.375269,634.644241,753.571221,691.608228,756.867210,155.739179,598.149169,241.748157,300.792131,534.21120,462.198104,459.37287,219.61780,234.41694,386.365
Brutowinstmarge 0.0810.0840.0810.0840.0840.0880.0850.0860.0920.0910.0920.0890.090.0960.093
Onderzoek- en ontwikkelingskosten 000000000000000
Algemene en administratieve kosten 29,726.88232,024.8124,731.15223,098.69723,991.59322,045.47617,941.51981,439.28715,140.05912,955.24811,744.66111,011.56849,889.69450,411.55748,453.685
Verkoop- en marketingkosten 28,289.2825,877.15828,507.56627,938.11627,616.39522,159.21221,031.76639,655.50512,144.07510,534.8149,348.3859,011.96220,803.17216,844.33816,420.146
Verkoop-, algemene en administratieve kosten 170,886.1257,901.96853,238.71851,036.81351,607.98844,204.68838,973.285121,094.79227,284.13423,490.06221,093.04620,023.5370,692.86667,255.89564,873.831
Overige kosten -3,643.483127,348.628119,684.005116,879.622111,869.4102,851.81891,317.029267.0522,080.15372.5131,842.1871,106.1-451.8-1,501.133-3,643.384
Bedrijfskosten 174,529.603185,250.596172,922.723167,916.435163,477.387146,835.223129,778.966121,361.843114,856.83497,960.62989,285.92780,339.79870,241.06667,255.89564,873.831
Bedrijfsresultaat 98,845.77273,962.09957,736.78552,772.34364,766.29263,105.47749,321.98747,879.90442,502.50631,851.62428,912.38222,936.68116,978.55112,978.5229,512.534
Bedrijfsresultaat ratio 0.0290.0230.0190.020.0240.0270.0230.0240.0250.0220.0220.020.0170.0160.029
Totaal overige inkomsten en kosten netto -50,885.004-37,497.965-39,814.268-45,032.967-52,796.809-34,508.313-28,633.522-30,632.375-25,728.767-21,602.75-13,469.741-9,672.908-10,862.209-10,722.492-12,923.691
Inkomen voor belasting 47,960.76836,464.13417,922.5177,739.37511,969.48428,590.9220,674.31317,247.5316,773.73910,248.87415,442.64113,263.7736,116.3422,256.02816,588.842
Inkomen voor belasting ratio 0.0140.0110.0060.0030.0040.0120.010.0090.010.0070.0120.0110.0060.0030.016
Belastingkosten 14,879.56612,000.0798,351.2814,935.0444,089.4769,146.6586,493.9686,141.6984,866.5412,930.3375,195.3513,415.5482,114.827748.6197,076.702
Nettowinst 33,087.52924,464.0559,571.2362,804.3317,880.00719,444.26214,180.34611,105.83211,907.1977,318.53710,247.2899,848.2244,001.5151,507.4099,512.141
Nettowinstmarge 0.010.0080.0030.0010.0030.0080.0070.0060.0070.0050.0080.0080.0040.0020.009
WPA (Winst Per Aandeel) 25.9719.27.512.26.1915.2618.8914.9816.069.8913.8113.274.911.9612.76
Verwaterde WPA 25.9719.27.512.26.1915.2618.8914.9816.069.8913.8113.274.911.9612.76
EBITDA 117,816.345101,899.17884,696.48669,342.35371,235.71868,192.2554,413.48247,997.81548,275.73738,667.08635,256.59127,850.79517,261.04712,460.98926,079.337
EBITDA ratio 0.0350.0320.0280.0260.0260.0290.0260.0240.0280.0270.0270.0240.0180.0150.026